⌘K

Login Start Free

Home/Filings/4/0000899866-17-000160

4//SEC Filing

Veneman Ann M 4

Accession 0000899866-17-000160

CIK 0000899866other

View on SEC.gov Company Profile

Filed

Sep 4, 8:00 PM ET

Accepted

Sep 5, 7:28 PM ET

Size

4.7 KB

Accession

0000899866-17-000160

Insider Transaction Report

Form 4

Period: 2017-09-05

ALEXION PHARMACEUTICALS INCALXN

Director

Transactions

Sale
Common Stock, par value $.0001 per share
2017-09-05$145.81/sh−835$121,751→ 5,480 total

Footnotes (1)

[F1]The transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.

Documents

1 file

4
wf-form4_150465406713931.xmlPrimary
FORM 4

Issuer

ALEXION PHARMACEUTICALS INC

CIK 0000899866

Entity typeother

Related Parties

1

filerCIK 0001493023

Filing Metadata

Form type: 4
Filed: Sep 4, 8:00 PM ET
Accepted: Sep 5, 7:28 PM ET
Size: 4.7 KB

View on SEC.gov